PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma

NCT01502228 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped No further funding

Conditions

Renal Cell Carcinoma

Interventions

DRUG: 150-Water
DRUG: 62Cu-ethylglyoxal bis
PROCEDURE: Positron Emission Tomography
DRUG: Sunitinib

Sponsor

Indiana University